Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PLMA In Brief

This article was originally published in The Tan Sheet

Executive Summary

Perrigo: Private labeler unveils Nasal Decongestant PE (phenylephrine 10 mg) in preparation for launch in the first half of 2005 at the Private Label Manufacturers Association trade show in Chicago Nov. 14-16. The 18-count tablets offer a decongestant alternative to solid tablet pseudoephedrine, Perrigo says. However, the product will face competition from same-ingredient private-label entries by Leiner and PL Developments, also slated to debut in early 2005 (see 1following story). Perrigo additionally plans pseudoephedrine 30 mg liquid caps and 15 mg grape-flavored syrup, as well as several new acetaminophen products for introduction in the in the first half of the year. The Allegan, Mich.-based firm also features Century Carb Multi (comparable to Wyeth's Centrum Carb Assist) in 45-tablet bottles and a store brand nutritional drink with plant sterols (equivalent to Abbott Labs' Ensure) in 6-8 oz. cans at the show...

Related Content

Topics

UsernamePublicRestriction

Register

PS097573

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel